Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Eric Bouvier, Pieter Muntendam, Stafford O'Kelly, David King, Jeffrey Cossman, Peter Wulff

Premium

BG Medicine this week announced that its board of directors has appointed Eric Bouvier as the firm's new president and CEO. The appointment became effective Jan. 9. Bouvier brings more than a decade of experience in the cardiovascular and molecular diagnostic markets. Previously, Bouvier was head of bioMerieux's immunoassay business.

Pieter Muntendam, who has served as president and CEO of BG Medicine for the past six years will now be the company's executive VP and chief medical officer.


The Personalized Medicine Coalition's board of directors has elected Stafford O'Kelly, president of Abbott Molecular, as its new chairman. David King, CEO of the Laboratory Corporation of America, is the board's treasurer. Jeffrey Cossman, president and founder of United States Diagnostic Standards, will serve as the board's secretary.


Agendia has hired Peter Wulff as its new VP of finance and chief financial officer. According to Agendia, Wulff brings to the company more than 25 years of financial management and corporate governance expertise in the life sciences industry, as well as more than 12 years of experience working at medical device companies. Wulff will split his time between Agendia's Amsterdam and Irvine, Calif., locations.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.